ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,391,686, issued on Aug. 19, was assigned to FOGHORN THERAPEUTICS INC. (Cambridge, Mass.).
"Compounds and uses thereof" was invented by Sabine K. Ruppel (Cambridge, Mass.), Zhaoxia Yang (Belmont, Mass.), Jason T. Lowe (East Bridgewater, Mass.), Johannes H. Voigt (Cambridge, Mass.), Matthew Netherton (Cambridge, Mass.) and Francois Brucelle (Belmont, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to methods and compositions for the treatment of BAF-related disorders such as cancers and viral infections."
The patent was filed on Jan. 29, 2020, under Application No. 17/425,132.
*For further information, including images...